ALKALOID AD Skopje, a leading pharmaceutical and chemical company, is headquartered in Skopje, North Macedonia (MK). Founded in 1936, the company has established itself as a key player in the industry, focusing on the production of a diverse range of products, including pharmaceuticals, herbal medicines, and active pharmaceutical ingredients (APIs). With a strong commitment to quality and innovation, ALKALOID AD has achieved significant milestones, expanding its operations across Europe and beyond. The company is renowned for its unique formulations and adherence to international standards, which have solidified its market position. Notable achievements include numerous awards for excellence in manufacturing and research, reflecting its dedication to advancing healthcare solutions.
In 2025, ALKALOID AD Skopje reported total carbon emissions of approximately 49,000,000 kg CO2e, comprising 6,460,680 kg CO2e from Scope 1, 2,623,910 kg CO2e from Scope 2, and 41,033,420 kg CO2e from Scope 3 emissions. This reflects a commitment to reducing greenhouse gas emissions, with significant reductions achieved in recent years. From 2022 to 2023, ALKALOID AD Skopje successfully reduced its Scope 1 emissions by 13% and Scope 2 emissions by 62%. These targets demonstrate the company's proactive approach to climate action, focusing on both direct and indirect emissions. The emissions data is not cascaded from any parent organization, indicating that ALKALOID AD Skopje independently tracks and reports its carbon footprint. The company continues to prioritise sustainability and is actively working towards further emissions reductions in the future.
Access structured emission data, company specific emission factors, and source documents.
ALKALOID AD Skopje's reported Scope 3 emissions increased by 287% last year and increased significantly since 2023. The vast majority of their reported carbon footprint comes from their upstream supply chain categories, with "Purchased Goods and Services" being the largest emissions source at 77% of total reported Scope 3 emissions. ALKALOID AD Skopje did not disclose Use of Sold Products and End of Life Treatment of Sold Products, which are relevant categories for their sector. These represent under reporting risk.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
ALKALOID AD Skopje has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.




You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Book a demo for your project.